Amphastar Pharmaceuticals Inc (29A.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 08:04AM CEST
| Previous close | 38.33 |
| Open | 38.47 |
| Bid | 38.50 x 0 |
| Ask | 39.13 x 0 |
| Day's range | 38.47 - 38.47 |
| 52-week range | 35.50 - 58.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
Detailed Analysis of Amphastar Pharmaceuticals Inc's Q1 2024 Financial Performance
Simply Wall St.Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
Amphastar Pharmaceuticals ( NASDAQ:AMPH ) First Quarter 2024 Results Key Financial Results Revenue: US$171.8m (up 23...
Insider MonkeyAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphastar Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the Amphastar Pharmaceuticals’ First Quarter Earnings Call. At this time, all participants are […]
© 2024 Yahoo. All rights reserved.